ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.
E R Kessler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.